MLICM
CYXT

Metropolitan Life Insurance Company (MetLife)’s Cyxtera Technologies, Inc. Class A Common Stock CYXT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CYXT Stock Details CYXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,721
Closed -$30.9K – 2378
2022
Q2 		$30.9K Buy
+2,721
New +$35.1K ﹤0.01% 1801

Other funds holding CYXT

BPA
BC Partners Advisors New York $9.17B AUM 97.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CYXT Position: Q3 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cyxtera Technologies, Inc. Class A Common Stock (CYXT) in Q3 2022, closing a stake of 2,721 shares — an estimated $30.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CYXT in Q2 2022 and held it in 1 quarter. The position peaked at $30.9K in Q2 2022. 91 funds tracked by Wall St. Rank hold CYXT as of Q3 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Cyxtera Technologies, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,721 Cyxtera Technologies, Inc. Class A Common Stock shares in Q3 2022, an estimated $30.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Cyxtera Technologies, Inc. Class A Common Stock in Q2 2022 and held it in 1 quarter.
  • Metropolitan Life Insurance Company (MetLife)'s Cyxtera Technologies, Inc. Class A Common Stock position peaked at $30.9K in Q2 2022.
  • 91 funds tracked by Wall St. Rank held Cyxtera Technologies, Inc. Class A Common Stock as of Q3 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.